Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView

NCT02287766 is registered in ClinicalTrials.gov with Epic Research & Diagnostics, Inc. as lead sponsor.

NCT NCT02287766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02287766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView
Lead sponsor
Epic Research & Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
November 30, 2014
Completion date
August 31, 2015
Enrollment
193 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome